| Names | |
|---|---|
|
IUPAC name
N-(2-Hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide
|
|
| Identifiers | |
|
3D model (Jmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.164.363 |
|
PubChem CID
|
|
| UNII | |
|
|
|
|
| Properties | |
| C7H10N4O4 | |
| Molar mass | 214.18 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
Etanidazole is a nitroimidazole drug used for its radiosensitizing properties. Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase. The result is that tissues become more sensitive to the ionizing radiation used in cancer treatment.